References

neurosurgery

Нейрохирургия

Russian journal of neurosurgery

1683-32952587-7569

Издательский дом "МедИНК"

10.63769/1683-3295-2015-0-2-86-91

neurosurgery-170

Research Article

ОБЗОРЫ ЛИТЕРАТУРЫ

LITERATURE REVIEW

СОВРЕМЕННЫЕ ПОДХОДЫ К ЛУЧЕВОЙ ТЕРАПИИ МЕТАСТАТИЧЕСКОГО ПОРАЖЕНИЯ ГОЛОВНОГО МОЗГА

The modern approaches to radiotherapy of brain metastatic lesions

Зинькович

Михаил Сергеевич

Zin’Kovich

M. S.

onco_doc@pochta.ru

Розенко

Людмила Яковлевна

Rozenko

L. Ya.

noemail@neicon.ru

Гусарева

Марина Александровна

Gusareva

M. A.

oncorad@mail.ru

Балязин-Парфенов

Игорь Викторович

Balyazin-Parfenov

I. V.

balyazinparfenov@mail.ru

Ростовский научно-исследовательский онкологический институтRussian Federation

2015

05102017

028691

2017

Зинькович М.С., Розенко Л.Я., Гусарева М.А., Балязин-Парфенов И.В.

Zin’Kovich M.S., Rozenko L.Y., Gusareva M.A., Balyazin-Parfenov I.V.

Данная работа распространяется под лицензией Creative Commons Attribution 4.0.

This work is licensed under a Creative Commons Attribution 4.0 License.

https://www.therjn.com/jour/article/view/170

Несмотря на высокий уровень современной доказательной медицины, продолжаются споры о методах и тактике лечения метастатического поражения головного мозга. Быстро увеличивающаяся доказательная база демонстрирует, что радиотерапия обеспечивает эффективный и предсказуемый локальный контроль над опухолью, позволяет продлить продолжительность жизни, а также уменьшить вероятность развития новых метастатических очагов. Комплексный подход с сочетанием облучения всего головного мозга с методиками локального воздействия обладает наибольшим лечебным потенциалом и позволяет добиться лучших результатов.

The discussions concerning methods and strategy treatment for brain metastatic lesions are still conducting in spite of high level of current evidence-based healthcare. The rapidly growing evidence database demonstrates that radiotherapy provides effective and predictive local control over tumor lesions as well as allows extanding the patient’s lifetime and decreasing the probability of new metastatic lesions development. The complex approach including combination of whole brain radiotherapy and various methods of local treatment has the most therapeutic capacity and allows achieving the best treatment outcomes.

внутримозговые метастазырадиотерапияоблучение всего головного мозгастереотаксическая радиохирургияbrain metastasesradiotherapywhole brain radiotherapystereotactic radiosurgery

References1

Григоров С.В. Ростов-на-Дону. 2008 г. Докторская диссертация: Новые подходы в комплексном лечении первичных злокачественных и метастатических опухолей центральной нервной системы.

Практические рекомендации по лекарственному лечению злокачественных опухолей (RUSSCO) под ред. Моисеенко В.М. 2013 стр.78.

Akyurek S, Chang E.L, Mahajan A, et al. Stereotactic radiosurgical treatment of cerebral metastases arising from breast cancer. Am J Clin Oncol 2007; 30(3): 310-4.

Andrews D.W, Scott C.B, Sperduto P.W, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004;363(9422):1665-72.

Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 2006;295(21):2483-91.

Assouline A, Levy A, Chargari C, Lamproglou I, Mazeron J.J, Krzisch C. Radiother Oncol. 2011 May;99(2):214-7. Whole br ain radiotherapy: prognostic factors and results of a radiation boost delivered through a conventional linear accelerator.

Bartsch R, Fromm S, Rudas M, et al. Intensified local treatment and systemic therapy significantly increase survival in patients with brain metastases from advanced breast cancer - a retrospective analysis. Radiother Oncol 2006; 80(3):313-7.

Brown P.D, Brown C.A, Pollock B.E, Gorman D.A, Foote R.L. Stereotactic radiosurgery for patients with ‘‘radioresistant’’ brain metastases. Neurosurgery 2008; 62(Suppl.):790-801.

Chao S.T, Barnett G.H, Vogelbaum M.A, et al. Salvage stereotactic radiosurgery effectively treats recurrences from whole-brain radiation therapy. Cancer 2008; 113(8):2198- 204.

Chen A.M, Jahan T.M, Jablons D.M, Garcia J, Larson D.A. Risk of cerebral metastases and neurological death after pathological complete response to neoadjuvant therapy for locally advanced nonsmall-cell lung cancer: clinical implications for the subsequent management of the brain. Cancer 2007;109(8):1668-75.

Chougule P.B, Burton-Williams M, Saris S,et al. Randomized treatment of brain metastasis with gamma knife radiosurgery, whole brain radiotherapy or both. Int J Radiat Oncol Biol Phys 2000; 48 (3):114.

Da Silva A.N, Nagayama K, Schlesinger D.J, Sheehan J.P. Gamma Knife surgery for brain metastases from gastrointestinal cancer. J Neurosurg 2009;111(3):423-30.

Eichler A.F, Kahle K.T, Wang D.L, et al. EGFR mutation status and survival after diagnosis of brain metastasis in nonsmall cell lung cancer. Neuro Oncol 2010; 12(11)1193-9

Flannery T.W, Suntharalingam M, Kwok Y, et al. Gamma knife stereotactic radiosurgery for synchronous versus metachronous solitary brain metastases from non-small cell lung cancer. Lung Cancer 2003;42(3):327-33.

Flannery T.W, Suntharalingam M, Regine W.F, et al. Long-term survival in patients with synchronous, solitary brain metastasis from non-small-cell lung cancer treated with radiosurgery. Int J Radiat Oncol Biol Phys 2008;72(1):19-23.

Gaudy-Marqueste C, Regis J.M, Muracciole X, et al. Gamma-Knife radiosurgery in the management of melanoma patients with brain metastases: a series of 106 patients without whole-brain radiotherapy. Int J Radiat Oncol Biol Phys 2006;65(3):809-16.

Goyal S, Prasad D, Harrell Jr F, Matsumoto J, Rich T, Steiner L. Gamma knife surgery for the treatment of intracranial metastases from breast cancer. J Neurosurg 2005;103(2):218-23.

Heisterkamp C, Haatanen T, Schild S.E, Rades D. Dose escalation in patients receiving whole-brain radiotherapy for brain metastases from colorectal cancer. Strahlenther Onkol 2010;186(2):70-5.

Jin J, Zhou X, Liang X, Huang R, Chu Z, Jiang J, Zhan Q. J Cancer Res Clin Oncol. 2013 Mar;139(3):403-8. Brain metastases as the first symptom of lung cancer: a clinical study from an Asian medical center.

Kalkanis S.N, Kondziolka D, Gaspar L.E, et al. The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 2010; 96(1):33-43.

Kased N, Binder D.K, McDermott M.W, et al. Gamma Knife radiosurgery for brain metastases from primary breast cancer. Int J Radiat Oncol Biol Phys 2009;75(4):1132-40.

Kocher M, Soffietti R, Abacioglu U, et al. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22,952-26,001 study. J Clin Oncol 2011;29(2):134-41.

Kondziolka D, Kano H, Harrison G.L, et al. Stereotactic radiosurgery as primary and salvage treatment for brain metastases from breast cancer. Clinical article. J Neurosurg 2011;114(3):792-800.

Langley R.E, Stephens R.J, Nankivell M, et al. Interim data from the Medical Research Council QUARTZ Trial: does whole brain radiotherapy affect the survival and quality of life of patients with brain metastases from non-small cell lung cancer? Clin Oncol (R Coll Radiol) 2013;25(3):e23- 30.

Lee D.S, Kim Y.S, Lee C.G, Lim J.H, Suh C.O, Kim H.J, Cho J. Clin Transl Oncol. 2013 Nov; 15(11):889-96. Early volumetric change and treatment outcome of metastatic brain tumors after external beam radiotherapy: differential radiotherapy for brain metastasis

Liew D.N, Kano H, Kondziolka D, et al. Outcome predictors of Gamma Knife surgery for melanoma brain metastases. Clinical article. J Neurosurg 2011;114(3):769-79

Linskey M.E, Andrews D.W, Asher A.L, et al. The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 2010;96(1):45-68.

Lippitz B.E. Cytokine patterns in patients with cancer: a systematic review. Lancet Oncol 2013;14(6):e218-28

Lippitz В, Lindquist С, Paddick I, Peterson D. Stereotactic radiosurgery in the treatment of brain metastases. Cancer Treatment Reviews 40 (2014) 48-59

Ma L.H, Li G, Zhang H.W, Wang Z.Y, Dang J, Zhang S, Yao L, Zhang X.M. J Neurosurg. 2012 Dec; 117 Suppl: 49-56. Hypofractionated stereotactic radiotherapy with or without whole-brain radiotherapy for patients with newlydiagnosed brain metastases from non-small cell lung cancer.

Manon R, O’Neill A, Knisely J, et al. Phase II trial of radiosurgery for one to three newly diagnosed brain metastases from renal cell carcinoma, melanoma, and sarcoma: an Eastern Cooperative Oncology Group study (E 6397). J Clin Oncol 2005;23(34):8870-6.

Marko N.F, Angelov L, Toms S.A, et al. Stereotactic radiosurgery as singlemodality treatment of incidentally identified renal cell carcinoma brain metastases. World Neurosurg 2010;73(3):186-93 discussion e29.

Mathieu D, Kondziolka D, Cooper P.B, et al. Gamma knife radiosurgery in the management of malignant melanoma brain metastases. Neurosurgery 2007;60(3):471-81.

Matsunaga S, Shuto T, Kawahara N, Suenaga J, Inomori S, Fujino H. Gamma Knife surgery for brain metastases from colorectal cancer. Clinical article. J Neurosurg 2011;114(3):782-9.

Mehta M.P, Tsao M.N, Whelan T.J, et al. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 2005;63(1):37-46.

Muacevic A, Kreth F.W, Tonn J.C, Wowra B. Stereotactic radiosurgery for multiple brain metastases from breast carcinoma. Cancer 2004;100(8): 1705-11.

Muacevic A, Wowra B, Siefert A, Tonn J.C, Steiger H.J, Kreth F.W. Microsurgery plus whole brain irradiation versus Gamma Knife surgery alone for treatment of single metastases to the brain: a randomized controlled multicentre phase III trial. J Neurooncol 2008;87(3):299-307.

Nieder C, Andratschke N, Grosu A.L, Molls M. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases. Strahlenther Onkol 2003; 179(1): 16-20.

Nieder C, Norum J, Dalhaug A, Aandahl G, Pawinski A. Radiotherapy versus best supportive care in patients with brain metastases and adverse prognostic factors. Clin Exp Metastasis. 2013 Aug;30(6):723-9

Nieder C, Thamm R, Astner S.T, Geinitz H, Molls M. Is whole-brain radiotherapy effective and safe in elderly patients with brain metastases? Oncology 2007;72(5-6):326-9.

O’Neill B.P, Iturria N.J, Link M.J, Pollock B.E, Ballman K.V, O’Fallon J.R. A comparison of surgical resection and stereotactic radiosurgery in the treatment of solitary brain me-tastases. Int J Radiat Oncol Biol Phys 2003;55(5):1169-76.

Paek S.H, Audu P.B, Sperling M.R, Cho J, Andrews D.W. Reevaluation of surgery for the treatment of brain metastases: review of 208 patients with single or multiple brain metastases treated at one institution with modern neurosurgical techniques. Neurosurgery 2005;56(5):1021-34 discussion 21-34.

Pan H.C, Sheehan J, Stroila M, Steiner M, Steiner L. Gamma knife surgery for brain metastases from lung cancer. J Neurosurg 2005;102(Suppl):128-33.

Powell J.W, Chung C.T, Shah H.R, et al. Gamma Knife surgery in the management of radioresistant brain metastases in high-risk patients with melanoma, renal cell carcinoma, and sarcoma. J Neurosurg 2008;109(Suppl):122-8.

Radbill A.E, Fiveash J.F, Falkenberg E.T, et al. Initial treatment of melanoma brain metastases using gamma knife radiosurgery: an evaluation of efficacy and toxicity. Cancer 2004;101(4):825-33.

Rades D, Kueter J.D, Hornung D, et al. Comparison of stereotactic radiosurgery (SRS) alone and whole brain radiotherapy (WBRT) plus a stereotactic boost (WBRT+SRS) for one to three brain metastases. Strahlenther Onkol 2008;184(12):655-62.

Rades D, Pluemer A, Veninga T, Hanssens P, Dunst J, Schild S.E. Whole-brain radiotherapy versus stereotactic radiosurgery for patients in recursive partitioning analysis classes 1 and 2 with 1 to 3 brain metastases. Cancer 2007;110(10):2285-92.

Rades D, Pluemer A, Veninga T, Schild S.E. Strahlenther Onkol. 2008 Nov;184(11):565-71. Comparison of different treatment approaches for one to two brain metastases in elderly patients.

Sanghavi S.N, Miranpuri S.S, Chappell R, et al. Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method. Int J Radiat Oncol Biol Phys 2001;51(2):426-34.

Selek U, Chang E.L, Hassenbusch 3rd S.J, et al. Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases. Int J Radiat Oncol Biol Phys 2004;59(4):1097-106.

Sheehan J.P, Sun M.H, Kondziolka D, Flickinger J, Lunsford L.D. Radiosurgery for non-small cell lung carcinoma metastatic to the brain: long-term outcomes and prognostic factors influencing patient survival time and local tumor control. J Neurosurg 2002; 97(6) :1276-81.

Sperduto P.W, Kased N, Roberge D, et al. The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer. J Neurooncol 2013;112(3):467-72.

Stockham A.L, Suh J.H, Chao S.T, Barnett G.H. Prog Neurol Surg. 2012;25:273-86. Management of recurrent brain metastasеs after radiosurgery.

Tsao M.N, Lloyd N, Wong R.K.S, Chow E, Rakovitch E, Laperriere N, Xu W, Sahgal A. Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases. Cochrane Database Syst Rev. 2012 Apr 18;4:CD003869

Tsao M.N, Rades D, Wirth A, et al. International practice survey on the management of brain metastases: third international consensus workshop on palliative radiotherapy and symptom control. Clin Oncol (R Coll Radiol) 2012;24(6): e81-92.

Tsao M.N, Rades D, Wirth A, Lo S.S, Danielson B.L, Gaspar L.E, et al. Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guideline. Pract Radiat Oncol 2012;2:210-25.

Varlotto J.M, Flickinger J.C, Niranjan A, Bhatnagar A, Kondziolka D, Lunsford L.D. The impact of whole-brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 2005;62(4): 1125-32.

Xu Z, Marko N.F, Chao S.T, et al. Relationship between HER2 status and prognosis in women with brain metastases from breast cancer. Int J Radiat Oncol Biol Phys 2012;82(5): e739-47.

Xu Z, Schlesinger D, Toulmin S, Rich T, Sheehan J. Impact of triple-negative phenotype on prognosis of patients with breast cancer brain metastases. Int J Radiat Oncol Biol Phys 2012; 84(3):612-8.

Yang H.C, Kano H, Lunsford L.D, Niranjan A, Flickinger J.C, Kondziolka D. Neurosurgery. 2011 Mar;68(3):682-90;What factors predict the response of larger brain metastases to radiosurgery?

The authors declare that there are no conflicts of interest present.